Inhibition of IP3 (Inositol 1,4,5-Trisphosphate) Receptors Retards SARS-CoV-2-Induced Endothelial von Willebrand

Xin-Yi Yu1, Xin-Yu Jia1, Ting-Yu Wang1

  • 1The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.

PubMed

Insights

Cytoskeleton-associated protein 4 (CKAP4) mediates COVID-19 coagulopathy by triggering calcium release from the endoplasmic reticulum, leading to increased von Willebrand factor secretion and thrombosis. Targeting IP3 receptors may prevent these effects.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Pathophysiology

Background:

  • COVID-19 patients exhibit hypercoagulability and thrombosis.
  • Cytoskeleton-associated protein 4 (CKAP4) is a receptor for SARS-CoV-2 spike protein and linked to COVID-19 coagulopathy.
  • The precise mechanism of CKAP4-mediated thrombosis remains unclear.

Purpose of the Study:

  • To investigate the signaling pathways linking spike protein-CKAP4 interaction to von Willebrand factor (vWF) secretion and thrombosis.
  • To identify potential therapeutic targets for COVID-19-associated coagulopathy.

Main Methods:

  • Treatment of endothelial cells (ECs) with SARS-CoV-2 spike protein.
  • Use of calcium chelators (BAPTA-AM), calcium channel blockers, and inositol 1,4,5-trisphosphate (IP3) receptor inhibitors.
  • Knockdown of IP3 receptor 1 (IP3R1).
  • Administration of KT-362, an IP3R-targeting drug.
  • In vivo studies in mice with endothelial-specific CKAP4 overexpression.

Main Results:

  • Spike protein induced vWF secretion, FVIII-vWF binding, and platelet adhesion in ECs, effects blocked by BAPTA-AM.
  • Calcium release from the endoplasmic reticulum (ER) via IP3 receptors (IP3Rs) was critical for these responses.
  • Inhibition of IP3Rs, particularly IP3R1, reversed spike protein-induced vWF secretion and procoagulant state.
  • KT-362 repressed spike protein-induced vWF secretion in vitro and in vivo.
  • IP3Rs activation promoted vWF secretion independently of CKAP4.

Conclusions:

  • IP3Rs-mediated calcium release from the ER is a key mechanism in spike protein-induced vWF secretion and thrombosis.
  • Targeting IP3Rs represents a potential therapeutic strategy for managing COVID-19-associated coagulopathy.

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.5K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
588
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K